Insmed

NASDAQ: INSM · Real-Time Price · USD
126.82
-0.93 (-0.72%)
At close: Aug 15, 2025, 12:23 PM

Insmed Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
398.11M 381.03M 363.71M 342.96M 328.61M 315.49M 305.21M 280.81M 269.47M 257.46M 245.36M 242.18M 221.21M 201.35M 188.46M 173.75M 170.64M 167.77M
Cost of Revenue
97.94M 90.83M 88.27M 80.56M 76.1M 70.46M 65.57M 60.2M 56.96M 56.77M 55.13M 55.34M 52.06M 46.5M 44.15M 41.73M 42.16M 41.28M
Gross Profit
300.17M 290.2M 275.44M 262.4M 252.51M 245.03M 239.63M 220.62M 212.51M 200.7M 190.23M 186.84M 169.15M 154.85M 144.31M 132.03M 128.47M 126.49M
Operating Income
-945.86M -877.19M -786.45M -734.31M -668.55M -718.87M -719.13M -694.13M -674.16M -526.95M -470.74M -416.54M -392.46M -392.71M -375.09M -370.55M -323.16M -288.71M
Interest Income
12.51M -10K 744K 10.6M 11.98M 11.63M 10.95M 9.41M 10.54M 10.18M 10.25M 1.93M 137K 171K 67K 67K 137K 306K
Pretax Income
-1.03B -1.01B -910.07M -860.85M -799.73M -744.23M -747.01M -721.95M -694.33M -545.2M -480.15M -433.17M -417.69M -439.25M -436.41M -424.99M -373.04M -317.76M
Net Income
-1.03B -1.01B -913.77M -864.28M -802.69M -746.89M -749.57M -723.63M -695.84M -546.68M -481.53M -434.39M -415.96M -437.63M -434.65M -423.89M -374.83M -319.37M
Selling & General & Admin
563.75M 515.56M 461.12M 408.13M 379.83M 357.69M 344.5M 328.45M 318.64M 281.57M 258.4M 250.19M 229.65M 239.47M 234.27M 225.03M 211.33M 203.82M
Research & Development
660.3M 629.86M 598.37M 555.67M 514.01M 564.23M 571.01M 558.75M 549.47M 441.03M 397.52M 349.11M 319.58M 295.71M 272.74M 264.21M 235.27M 206.36M
Other Expenses
35.51M 35.24M 14.58M 16.75M 1.09M 867K 3.23M 2.32M 3.3M 5.05M 5.05M 3.79M 2.53M 1.1M -202K 217K 213K 326K
Operating Expenses
1.26B 1.18B 1.08B 981.01M 896.36M 925.71M 920.56M 892.25M 873.17M 727.65M 660.97M 604.35M 554.28M 540.23M 512.07M 494.28M 451.63M 415.2M
Interest Expense
84.7M 83.63M 82.01M 81.24M 80.02M 78.81M 78.87M 74.53M 58.77M 42.34M 25.63M 20.53M 28.42M 36.2M 40.47M 36.62M 32.56M 29.71M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a 1.8M 1.8M 1.8M 1.8M n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
1.36B 1.27B 1.16B 1.06B 972.46M 996.17M 986.14M 952.45M 930.13M 784.41M 716.1M 659.69M 606.34M 586.73M 556.22M 536.01M 493.8M 456.48M
Income Tax Expense
4.43M 4.03M 3.71M 3.44M 2.97M 2.66M 2.56M 1.68M 1.51M 1.48M 1.38M 1.22M -1.73M -1.61M -1.76M -1.1M 1.8M 1.6M
Shares Outstanding (Basic)
189.3M 180.86M 179.02M 173.72M 154.7M 148.46M 144.81M 142.9M 137.55M 136.35M 132.69M 120.32M 119.56M 118.28M 118.5M 117.09M 109.58M 102.97M
Shares Outstanding (Diluted)
189.3M 180.86M 179.02M 173.72M 154.7M 148.46M 144.81M 142.9M 137.55M 136.35M 132.69M 120.79M 119.6M 118.93M 118.5M 117.09M 109.58M 103.04M
EPS (Basic)
-5.71 -5.95 -5.59 -5.55 -5.39 -5.23 -5.34 -5.27 -5.25 -4.27 -3.9 -3.64 -3.51 -3.78 -3.87 -3.92 -3.59 -3.16
EPS (Diluted)
-5.71 -5.95 -5.59 -5.55 -5.39 -5.23 -5.34 -5.27 -5.25 -4.27 -3.9 -3.64 -3.51 -3.78 -3.87 -3.92 -3.59 -3.16
EBITDA
-934.78M -915.13M -814.97M -766.51M -706.4M -650.59M -650.99M -628.91M -618.59M -488.98M -442M -399.19M -371.67M -379.4M -373.92M -367.02M -321.38M -274.05M
EBIT
-947.03M -927.43M -828.06M -780.57M -720.67M -666.38M -670.76M -653.06M -642.02M -508.5M -459.34M -414.01M -389.81M -404.86M -397.29M -389.52M -341.98M -289.45M
Depreciation & Amortization
12.36M 11.31M 11.01M 11.01M 12.17M 15.59M 19M 20.36M 20.27M 23.77M 22.42M 23.34M 25M 23.64M 27.58M 26.13M 24.24M 19.49M